Kutna, Viera, O'Leary, Valerie, Newman, Ehren, Hoschl, Cyril and Ovsepian, Saak (2021) Revisiting brain tuberous sclerosis complex in rat and human: shared molecular and cellular pathology leads to distinct neurophysiological and behavioural phenotypes. Neurotherapeutics - The Journal of the American Society for Experimental Neurotherapeutics, 18 (2). pp. 845-858. ISSN 1933-7213 (Print), 1878-7479 (Online) (doi:https://doi.org/10.1007/s13311-020-01000-7)

PDF (AAM) 35162_OVSEPIAN_Revisiting_brain_tuberous_sclerosis.pdf - Accepted Version Restricted to Repository staff only Download (15MB) | Request a copy

Abstract

Tuberous sclerosis complex (TSC) is a dominant autosomal genetic disorder caused by loss-of-function mutations in TSC1 and TSC2, which lead to constitutive activation of the mammalian target of rapamycin C1 (mTORC1) with its decoupling from regulatory inputs. Because mTORC1 integrates an array of molecular signals controlling protein synthesis and energy metabolism, its unrestrained activation inflates cell growth and division, resulting in the development of benign tumors in the brain and other organs. In humans, brain malformations typically manifest through a range of neuropsychiatric symptoms, among which mental retardation, intellectual disabilities with signs of autism, and refractory seizures, which are the most prominent. TSC in the rat brain presents the first-rate approximation of cellular and molecular pathology of the human brain, showing many instructive characteristics. Nevertheless, the developmental profile and distribution of lesions in the rat brain, with neurophysiological and behavioral manifestation, deviate considerably from humans, raising numerous research and translational questions. In this study, we revisit brain TSC in human and Eker rats to relate their histopathological, electrophysiological, and neurobehavioral characteristics. We discuss shared and distinct aspects of the pathology and consider factors contributing to phenotypic discrepancies. Given the shared genetic cause and molecular pathology, phenotypic deviations suggest an incomplete understanding of the disease. Narrowing the knowledge gap in the future should not only improve the characterization of the TSC rat model but also explain considerable variability in the clinical manifestation of the disease in humans.

Item Type:	Article
Uncontrolled Keywords:	mTOR signalling; autism spectrum disorders; hamartoma; neoplasia; TSC1; TSC2; refractory epilepsy
Subjects:	Q Science > QM Human anatomy R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Faculty / School / Research Centre / Research Group:	Faculty of Engineering & Science Faculty of Engineering & Science > Biology & Biotechnology Research Group Faculty of Engineering & Science > School of Science (SCI)
Related URLs:	Publisher
Last Modified:	11 Feb 2022 10:44
URI:	http://gala.gre.ac.uk/id/eprint/35162

Actions (login required)

View Item

Downloads